Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. S-1/A Offering Registration Statement
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CERTNAS Other Certification by the Nasdaq Stock Market
  9. UPLOAD Other SEC-generated Letter
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. 8-A12B Other Registration of Securities
  12. S-1/A Offering Registration Statement
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. UPLOAD Other SEC-generated Letter
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-1/A Offering Registration Statement
  17. S-1/A Offering Registration Statement
  18. S-1/A Offering Registration Statement
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-1 Offering Registration Statement

Page 41 of 42 · 823 filings